Thus, targeting TRP channels and neuropeptide receptors might represent a promising new therapeutic approach in various inflammatory disorders such as inflammatory bowel disease, asthma, COPD, and atherosclerosis. The gene discussed is NPSR1; the disease is inflammatory bowel disease.